TrivarX Overview
- Year Founded
-
1987
- Status
-
Public
- Employees
-
17
- Stock Symbol
-
TRI
- Investments
-
7
TrivarX General Information
Description
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability. The Company has one operating segment, being the research, development and commercialisation of its diagnostic and pharmaceutical products, and two geographical locations, being Australia and the United States.
Contact Information
Website
www.trivarx.comCorporate Office
- 647 Beaufort Street
- Mount Lawley
- Perth, Western Australia 6050
- Australia
Corporate Office
- 647 Beaufort Street
- Mount Lawley
- Perth, Western Australia 6050
- Australia
TrivarX Timeline
TrivarX Stock Performance
As of 13-Nov-2026, TrivarX’s current market cap is $7.07M with 1.15B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.07M | 1.15B | 872K |
TrivarX Financials Summary
As of 30-Sep-2026, TrivarX has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 6,445 | 14,387 | 2,838 | 6,645 |
| EBITDA | (1,553) | (560) | (873) | |
| Net Income | (5,936) | (610) | (940) | |
| Total Assets | 11,379 | 8,807 | 7,398 | |
| Total Debt | 88 | 110 | 11 |
TrivarX Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TrivarX Comparisons
Industry
Financing
Details
TrivarX Competitors (4)
One of TrivarX’s 4 competitors is Epic (Other Healthcare Technology Systems), a Private Equity-Backed company based in Verona, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Epic (Other Healthcare Technology Systems) | Private Equity-Backed | Verona, WI | ||||
| Veradigm | Formerly VC-backed | Chicago, IL | ||||
| Soma Analytics | Formerly VC-backed | San Francisco, CA | ||||
| Telemynd | Private Equity-Backed | Maynard, MA |
TrivarX Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TrivarX Patents
TrivarX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026096630-A1 | Determination of patient behavioral health state based on analysis of metrics derived from patient heart waveforms | Pending | 01-Nov-2024 | ||
| WO-2023244660-A1 | Determination of patient behavioral health state based on patient heart and brain waveforms metric analysis | Inactive | 14-Jun-2022 | ||
| US-20250366750-A1 | Determination of physiological state based on analysis of metrics derived from patient heart and brain waveforms | Pending | 14-Jun-2022 | ||
| US-20240393934-A1 | Biometric and user-interaction analysis and recommendation system | Pending | 01-Oct-2021 | ||
| WO-2023056092-A1 | Biometric and user-interaction analysis and recommendation system | Inactive | 01-Oct-2021 | G06F3/04847 |
TrivarX Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TrivarX Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
TrivarX Investments & Acquisitions (7)
TrivarX’s most recent deal was a Corporate Asset Purchase with Nucleics (Stabl-Im in Woollahra, Australia). The deal was made on 30-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nucleics (Stabl-Im in Woollahra, Australia) | 30-Jan-2026 | Corporate Asset Purchase | Buildings and Property | ||
| Vital Conversations | 12-Apr-2018 | Merger/Acquisition | Consulting Services (B2B) | ||
| Heartlink (Key IP License) | 19-Apr-2016 | Corporate Asset Purchase | Buildings and Property | ||
| Invatec Health | 30-Apr-2015 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Frontier Gasfields | 01-Mar-2011 | Secondary Transaction - Open Market | Energy Exploration |
TrivarX ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
Rank
Percentile
TrivarX Exits (2)
TrivarX’s most recent exit was on 01-Mar-2011 from Frontier Gasfields. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Frontier Gasfields | 01-Mar-2011 | Completed |
|
||
| Frontier Gasfields | Secondary Transaction - Private | Completed |
TrivarX FAQs
-
When was TrivarX founded?
TrivarX was founded in 1987.
-
Where is TrivarX headquartered?
TrivarX is headquartered in Perth, Australia.
-
What is the size of TrivarX?
TrivarX has 17 total employees.
-
What industry is TrivarX in?
TrivarX’s primary industry is Decision/Risk Analysis.
-
Is TrivarX a private or public company?
TrivarX is a Public company.
-
What is TrivarX’s stock symbol?
The ticker symbol for TrivarX is TRI.
-
What is the current market cap of TrivarX?
The current market capitalization of TrivarX is $7.07M.
-
Who are TrivarX’s competitors?
Epic (Other Healthcare Technology Systems), Veradigm, Soma Analytics, and Telemynd are competitors of TrivarX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
